C28H38N2O7S
546.7 g/mol
APIWarning
Linerixibat
CAS1345982-69-5
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Linerixibat is a pharmaceutical raw material and an ileal bile acid transporter (IBAT) inhibitor. It is primarily supplied for use in pharmaceutical manufacturing, particularly in research related to cholestatic pruritus.
Pharmaceutical raw material for IBAT inhibitor manufacturingResearch compound in cholestatic pruritus studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1345982-69-5
Related Compounds
ApplicationSame Use
Elobixibat
CAS439087-18-0
pharmaceutical raw material
ApplicationSame Use
Odevixibat
CAS501692-44-0
pharmaceutical raw material
ReferenceSame Category
3-O-methyltolcapone
CAS134612-80-9
pharmaceutical raw material
ReferenceSame Category
Dehydro Ivabradine Oxalate
CAS1346558-08-4
pharmaceutical raw material
ReferenceSame Category
Adefovir Diphosphate Triethylamine Salt
CAS1346598-45-5
pharmaceutical raw material
ReferenceSame Category
Azilsartan-d5
CAS1346599-45-8
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-1lambda6,4-benzothiazepin-8-yl]methylamino]pentanedioic acid
InChIKey
CZGVOBIGEBDYTP-VSGBNLITSA-N
SMILES
CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC
Synonyms (17)
- Linerixibat (JAN/USAN)
- GSK 2330672
- Iinerixibat
- Linerixibat
- Lynavoy (TN)
- US9040518, 26
- WHO 10729
- linerixibatum